Mechanism and Therapeutic Reversal of Immune Suppression in Cancer
Open Access
- 1 June 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (11), 5067-5069
- https://doi.org/10.1158/0008-5472.can-07-0897
Abstract
The meeting began with a discussion of the historical perspective of cancer immunotherapy from bench to bedside ( 1). The concept of “checkpoint blockades” was described as the body's attempt at preventing autoimmunity and thereby thwarting attempts at harnessing the immune system in the eradication of cancer. [Cancer Res 2007;67(11):5067–9]This publication has 14 references indexed in Scilit:
- Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironmentNature Reviews Immunology, 2007
- Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulationCurrent Opinion in Immunology, 2006
- The role of stroma in immune recognition and destruction of well-established solid tumorsCurrent Opinion in Immunology, 2006
- Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppressionSeminars in Cancer Biology, 2006
- Combination of p53 Cancer Vaccine with Chemotherapy in Patients with Extensive Stage Small Cell Lung CancerClinical Cancer Research, 2006
- Immunotherapy for pancreatic cancer — science driving clinical progressNature Reviews Cancer, 2005
- Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppressionCancer Immunology, Immunotherapy, 2005
- Mechanisms and functional significance of tumour-induced dendritic-cell defectsNature Reviews Immunology, 2004
- Immunoregulatory T cells in tumor immunityCurrent Opinion in Immunology, 2004
- Cancer vaccines: between the idea and the realityNature Reviews Immunology, 2003